Project Details
Description
A Study of a Topical formulation of Nitroglycerin, Vascana, (MQX-503), and Matching Vehicle in the Treatment and Prevention of Symptoms Associated with Raynaud's Phenomenon
Status | Finished |
---|---|
Effective start/end date | 9/18/09 → 12/1/10 |
Funding
- MediQuest Therapeutics, Inc.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.